BIOS Capital Management as of March 31, 2026
Portfolio Holdings for BIOS Capital Management
BIOS Capital Management holds 6 positions in its portfolio as reported in the March 2026 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Actuate Therapeutics (ACTU) | 52.1 | $28M | 10M | 2.74 | |
| Ocuphire Pharma (IRD) | 31.7 | $17M | 3.7M | 4.55 | |
| Cognition Therapeutics (CGTX) | 8.6 | $4.6M | 6.0M | 0.76 | |
| Rein Therapeutics Com New (RNTX) | 4.9 | $2.6M | 2.0M | 1.30 | |
| Lantern Pharma (LTRN) | 2.2 | $1.2M | 864k | 1.37 | |
| In8bio Com New (INAB) | 0.5 | $248k | 168k | 1.48 |
